Kevin Adam

Nov 19, 2024 | edmontonjournal.com | Kevin Adam

Opinion: Alberta needs more women in the skilled trades Women training in the sheet metal shop of the Women Building Futures building in downtown Edmonton, file photo. Photo by Ed Kaiser /PostmediaArticle contentThe great Alberta building boom is on. The province experienced an astounding 54-per-cent increase in home construction in the first half of 2024, with July seeing the highest number of housing starts ever recorded. And that’s just the beginning.

Aug 7, 2024 | jdsupra.com | Kevin Adam |Eugene Hutchinson |Cansu Gunel

August 7, 2024 Kevin Adam, Cansu Gunel, Eugene Hutchinson, Constantin Nuernberger White & Case LLP + Follow x Following x Following - Unfollow Contact To embed, copy and paste the code into your website or blog: It has been a busy year for issues related to drug pricing, and with the election around the corner, litigation issues that have been developing over the last few years are likely to be a key focus for the second half of 2024. The FTC and private litigants are testing the limits of...

Mar 27, 2024 | observer-me.com | Kevin Adam

Screenshot (96) Photo courtesy of Shawn LaatschECLIPSE PROJECT — An Image of the 2023 eclipse in Australia taken by University of Maine astronomer Shawn Laatsch, who is heading a NASA eclipse project for the April 8 eclipse. By Kevin Adam, Baxter State Park director On the afternoon of April 8, a total solar eclipse will pass through the Katahdin region of Maine. This event is a rare and special occasion for our state.

Mar 10, 2024 | pressherald.com | Kevin Adam

On the afternoon of April 8, a total solar eclipse will pass through the Katahdin region of Maine. This event is a rare and special occasion for our state. The path of totality will pass directly over Katahdin, Millinocket, Patten and many other communities in the region. People from all over Maine and the country plan to visit the Katahdin region to view the eclipse.

Aug 30, 2023 | jdsupra.com | Kevin Adam |Eugene Hutchinson |Constantin Nuernberger

While only slightly past the midway point of 2023, it has already been a busy year for developments in drug pricing. Notably, CMS released its final guidance in preparation for price negotiations and the first 10 drugs covered under the IRA, constitutional challenges to the IRA's drug-pricing provisions are mounting, and Congress is considering several new bills that seek to ban specific PBM practices and target certain types of conduct by drug manufacturers.